Literature DB >> 1864483

Insulin treatment prevents diabetes mellitus but not thyroiditis in RT6-depleted diabetes resistant BB/Wor rats.

P A Gottlieb1, E S Handler, M C Appel, D L Greiner, J P Mordes, A A Rossini.   

Abstract

Prophylactic insulin administration is known to prevent hyperglycaemia in diabetes prone BB rats and non-obese diabetic mice. This study investigated the effect of insulin treatment on the development of overt diabetes, clinically inapparent anti-islet autoreactivity, and thyroiditis in RT6-depleted diabetes resistant BB rats. Fewer than 1% of these animals develop spontaneous diabetes, but if depleted of RT6- T cells greater than 50% become hyperglycaemic. We treated 30-day-old diabetes resistant rats with anti-RT6.1 monoclonal antibody, exogenous insulin, or both. Up to 60 days of age, 16 of 20 rats given antibody alone became diabetic, compared with 1 of 20 also treated with antibody plus insulin. Up to 110 days of age, only 1 of 10 rats treated with both insulin and antibody between 30 and 60 days became diabetic. Histologic study of non-diabetic insulin plus anti-RT6 antibody treated rats revealed insulitis in 3 of 9 at 60 days old, and insulitis in 3 of 8 and thyroiditis in 6 of 7 at 110 days of age. Non-diabetic animals were also found to harbour autoreactive spleen cells that adoptively transferred diabetes. Splenocytes from 60 or 110-day-old non-diabetic donors that had been treated with insulin and antibody between 30 and 60 days of age induced diabetes in 7 of 13 and 6 of 8 adoptive recipients respectively. We conclude that insulin treatment prevents clinical diabetes in the RT6-depleted diabetes resistant BB rat, but this treatment does not prevent the development of autoreactive cell populations that cause thyroiditis and adoptively transfer diabetes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1864483     DOI: 10.1007/bf00404999

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  20 in total

1.  Streptozotocin-induced pancreatic insulitis in mice. Morphologic and physiologic studies.

Authors:  A A Like; M C Appel; R M Williams; A A Rossini
Journal:  Lab Invest       Date:  1978-04       Impact factor: 5.662

2.  High-glucose stimulation of 64,000-Mr islet cell autoantigen expression.

Authors:  O Kämpe; A Andersson; E Björk; A Hallberg; F A Karlsson
Journal:  Diabetes       Date:  1989-10       Impact factor: 9.461

Review 3.  Mechanisms of pancreatic beta-cell destruction in type I diabetes.

Authors:  J Nerup; T Mandrup-Poulsen; J Mølvig; S Helqvist; L Wogensen; J Egeberg
Journal:  Diabetes Care       Date:  1988 Nov-Dec       Impact factor: 19.112

4.  Effect of L-thyroxine administration on the incidence of iodine induced and spontaneous lymphocytic thyroiditis in the BB/Wor rat.

Authors:  W Reinhardt; T L Paul; E M Allen; S Alex; Y N Yang; M C Appel; L E Braverman
Journal:  Endocrinology       Date:  1988-03       Impact factor: 4.736

5.  Adoptive transfer of autoimmune diabetes and thyroiditis to athymic rats.

Authors:  U McKeever; J P Mordes; D L Greiner; M C Appel; J Rozing; E S Handler; A A Rossini
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

6.  Dependence of antigen expression on functional state of beta-cells.

Authors:  K Aaen; J Rygaard; K Josefsen; H Petersen; C H Brogren; T Horn; K Buschard
Journal:  Diabetes       Date:  1990-06       Impact factor: 9.461

7.  The inhibitory effect of large doses of methimazole on iodine induced lymphocytic thyroiditis and serum anti-thyroglobulin antibody titers in BB/Wor rats.

Authors:  W Reinhardt; M C Appel; S Alex; Y N Yang; L E Braverman
Journal:  J Endocrinol Invest       Date:  1989-09       Impact factor: 4.256

8.  Characterization of monoclonal antibodies that define rat T cell alloantigens.

Authors:  J M Ely; D L Greiner; D M Lubaroff; F W Fitch
Journal:  J Immunol       Date:  1983-06       Impact factor: 5.422

9.  A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus.

Authors:  S C Shah; J I Malone; N E Simpson
Journal:  N Engl J Med       Date:  1989-03-02       Impact factor: 91.245

10.  Insulin treatment improves the spontaneous remission of neonatal streptozotocin diabetes in the rat.

Authors:  B Portha; L Picon
Journal:  Diabetes       Date:  1982-02       Impact factor: 9.461

View more
  9 in total

Review 1.  Latent autoimmune diabetes in adults (LADA).

Authors:  Ramachandra G Naik; Jerry P Palmer
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

2.  The Effect of DPT-1 Intravenous Insulin Infusion and Daily Subcutaneous Insulin on Endogenous Insulin Secretion and Postprandial Glucose Tolerance.

Authors:  Wei Hao; Carla J Greenbaum; Jeffrey P Krischer; David Cuthbertson; Jennifer B Marks; Jerry P Palmer
Journal:  Diabetes Care       Date:  2015-02-26       Impact factor: 19.112

Review 3.  Prophylactic insulin. Is it 'safe'?

Authors:  K Buschard; T Bock; C Pedersen; I Hageman; K Josefsen
Journal:  Drug Saf       Date:  1993-11       Impact factor: 5.606

Review 4.  IDDM: an islet or an immune disease?

Authors:  C Boitard; E Larger; J Timsit; P Sempe; J F Bach
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

Review 5.  Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease.

Authors:  John P Driver; David V Serreze; Yi-Guang Chen
Journal:  Semin Immunopathol       Date:  2010-04-28       Impact factor: 9.623

Review 6.  100 Years of Insulin: Lifesaver, immune target, and potential remedy for prevention.

Authors:  Anette-Gabriele Ziegler; Thomas Danne; Carolin Daniel; Ezio Bonifacio
Journal:  Med (N Y)       Date:  2021-09-15

7.  Tolbutamide reduces the incidence of diabetes mellitus, but not insulitis, in the non-obese-diabetic mouse.

Authors:  A J Williams; P E Beales; J Krug; E Procaccini; A Signore; S Xu; E A Gale; P Pozzilli
Journal:  Diabetologia       Date:  1993-06       Impact factor: 10.122

8.  Thymic epithelial defects and predisposition to autoimmune disease in BB rats.

Authors:  J Doukas; J P Mordes; C Swymer; D Niedzwiecki; R Mason; J Rozing; A A Rossini; D L Greiner
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

9.  Pancreatic islet beta cells drive T cell-immune responses in the nonobese diabetic mouse model.

Authors:  E Larger; C Bécourt; J F Bach; C Boitard
Journal:  J Exp Med       Date:  1995-05-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.